※ 引述《askacis (ASKA)》之铭言：
: 拿到EUA的那几家药厂基本上测新型变种也是先直接测中和抗体，
: 因为根本没时间让你重作大型临床，至于之后会不会补大型临床实验，
: 就要看他们之后有没有发paper了
A test negative case-control design was used to
estimate odds ratios for testing positive to SARS-CoV-2
in all vaccinated compared with unvaccinated people
with compatible symptoms who were tested using
polymerase chain reaction (PCR).
Effectiveness of COVID-19 vaccines against the B.1.617.2 variant
https://doi.org/10.1101/2021.05.22.21257658
paper 已经发了
妳是在作什么中和抗体梦?
他们数据都有了 直接统计技术即可